Evaluation of prevalence of COPD according to different criteria Source: Eur Respir J 2002; 20: Suppl. 38, 124s Year: 2002
Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection. Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018
Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017
An evaluation of the accuracy of Mini-Wright Peak Flow meter in patients with airflow limitation Source: Eur Respir J 2005; 26: Suppl. 49, 337s Year: 2005
Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017
Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012
The current ERS, BTS, ATS and GOLD classification criteria underestimate the impact of COPD on patients Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002
Association between symptomatic improvements and outcome: responder analysis of SERVE-HF Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
Comparison between results of spirometry performed with the ATS/ERS quantitative criteria and simple visual inspection criteria Source: International Congress 2017 – Best abstracts in lung function Year: 2017
Response to omalizumab treatment according to blood eosinophil count: Results of a French real-world study (STELLAIR) Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
The classification of severity of COPD-patients in GOLD- guideline Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003
Quantification and treatment patterns of real-world patients classified by the GOLD 2011 strategy Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Pre- and post- bronchodilator FEV1 does not perturb a multidimensional system (IDS) for categorising the clinical impact of COPD: comparison of ERS, BTS and GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 215s Year: 2003
Assessing asthma control using a composite measure based on GINA/NIH guidelines: an analysis of GOAL baseline data Source: Eur Respir J 2002; 20: Suppl. 38, 47s Year: 2002
Definition, epidemiology and diagnostic criteria of IPF and how these guidelines were developed Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: evidence based guidelines and recommendations for clinical management - Results of the joint ATS/ERS/JRS taskforce Year: 2009
Effectiveness of tiotropium in low-risk patients according to new GOLD severity grading Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
The inclusion of peak expiratory flow (PEF) among selection criteria of the ”best test“ may increase diagnostic ability of forced vital capacity (FVC) Source: Eur Respir J 2001; 18: Suppl. 33, 202s Year: 2001
Can high quality spirometry according to ERS criteria be obtained regardless of age? Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages Year: 2014